Vericel Corporation (VCEL)
NASDAQ
Market Cap
$2.22B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
786 of 809
Rank in Industry
432 of 445
Largest Insider Buys in Sector
VCEL Stock Price History Chart
VCEL Stock Performance
About Vericel Corporation
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Insider Activity of Vericel Corporation
Over the last 12 months, insiders at Vericel Corporation have bought $0 and sold $14.84M worth of Vericel Corporation stock.
On average, over the past 5 years, insiders at Vericel Corporation have bought $0 and sold $9.55M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,780 shares for transaction amount of $20,592 was made by Rubino Alan L (director) on 2018‑03‑16.
List of Insider Buy and Sell Transactions, Vericel Corporation
| 2024-06-24 | Sale | Flynn Sean C. | Chief Legal Officer | 1,474 0.003% | $45.84 | $67,568 | -2.81% | |
| 2024-06-21 | Sale | Flynn Sean C. | Chief Legal Officer | 6,772 0.0145% | $45.02 | $304,875 | +1.20% | |
| 2024-06-20 | Sale | Flynn Sean C. | Chief Legal Officer | 6,754 0.0145% | $45.04 | $304,200 | +0.76% | |
| 2024-06-13 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0358% | $43.10 | $754,250 | +3.02% | |
| 2024-06-12 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0367% | $44.12 | $772,100 | +1.14% | |
| 2024-05-20 | Sale | Hopper Jonathan Mark | Chief Medical Officer | 10,000 0.0201% | $49.99 | $499,900 | -10.19% | |
| 2024-05-16 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0356% | $47.85 | $837,375 | -3.17% | |
| 2024-05-15 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0362% | $49.67 | $869,225 | -6.46% | |
| 2024-04-18 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0368% | $44.59 | $780,325 | +6.56% | |
| 2024-04-17 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0363% | $46.47 | $813,225 | +0.86% | |
| 2024-03-27 | Sale | ZERBE ROBERT L MD | director | 3,278 0.0067% | $51.57 | $169,046 | -9.04% | |
| 2024-03-14 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0359% | $44.02 | $770,350 | +6.88% | |
| 2024-03-13 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0364% | $44.67 | $781,725 | +5.77% | |
| 2024-03-11 | Sale | Halpin Michael | Chief Operating Officer | 7,874 0.0163% | $44.71 | $352,047 | +5.32% | |
| 2024-03-08 | Sale | Flynn Sean C. | SVP, General Counsel | 8,115 0.0168% | $45.33 | $367,853 | +3.76% | |
| 2024-03-07 | Sale | SIEGAL JONATHAN | Principal Accounting Officer | 1,634 0.0034% | $45.00 | $73,530 | +4.61% | |
| 2024-02-20 | Sale | ZERBE ROBERT L MD | director | 722 0.0015% | $50.01 | $36,107 | -5.17% | |
| 2024-02-15 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0377% | $48.85 | $854,875 | -4.88% | |
| 2024-02-14 | Sale | Colangelo Dominick | President and CEO | 17,500 0.0363% | $46.99 | $822,325 | -1.14% | |
| 2024-01-29 | Sale | ZERBE ROBERT L MD | director | 2,300 0.0048% | $44.22 | $101,706 | +5.71% |
Insider Historical Profitability
19.12%
| Colangelo Dominick | President and CEO | 220752 0.3562% | $45.76 | 1 | 25 | +18.13% |
| Hopper Jonathan Mark | Chief Medical Officer | 58116 0.1111% | $45.76 | 0 | 8 | |
| Wotton Paul K | director | 26802 0.0562% | $45.76 | 0 | 6 | |
| ZERBE ROBERT L MD | director | 23395 0.049% | $45.76 | 0 | 10 | |
| Flynn Sean C. | SVP, General Counsel | 487 0.0094% | $45.76 | 0 | 9 | |
| SIEGAL JONATHAN | Principal Accounting Officer | 1400 0.0027% | $45.76 | 0 | 4 | |
| Halpin Michael | Chief Operating Officer | 949 0.0017% | $45.76 | 0 | 9 | |
| Consonance Capital Management LP | 10 percent owner | 2232940 4.6788% | $45.76 | 0 | 1 | |
| ARMSTRONG R DOUGLAS PHD | Chairman and CEO | 573763 1.2022% | $45.76 | 2 | 5 | <0.0001% |
| MAYLEBEN TIMOTHY M | President and CEO | 133000 0.2787% | $45.76 | 9 | 0 | +21.76% |
| MICHEL GERARD J | CFO and VP, Corp. Development | 123182 0.2581% | $45.76 | 1 | 12 | +18.13% |
| CRESSWELL RONALD M | director | 40000 0.0838% | $45.76 | 2 | 0 | +3.5% |
| Hock Janet Mary | VP Global Research & CSO | 37136 0.0778% | $45.76 | 0 | 1 | |
| Brennan Gerald JR | VP Admin. and Finance, CFO | 30000 0.0629% | $45.76 | 2 | 0 | <0.0001% |
| SUDOVAR STEPHEN | director | 26900 0.0564% | $45.76 | 2 | 0 | <0.0001% |
| HAMPSON BRIAN | VP Product Develop | 18673 0.0391% | $45.76 | 0 | 1 | |
| DUNBAR GEORGE W JR | director | 12750 0.0267% | $45.76 | 3 | 0 | <0.0001% |
| Orlando Daniel | Chief Operating Officer | 12518 0.0262% | $45.76 | 1 | 1 | +18.13% |
| SIMS NELSON M | director | 10000 0.021% | $45.76 | 1 | 0 | <0.0001% |
| FINGERLE LINDA M | 6927 0.0145% | $45.76 | 18 | 1 | +41.69% | |
| GILMAN STEVEN C | 5200 0.0109% | $45.76 | 0 | 8 | ||
| CAMPBELL MARY L | director | 1633 0.0034% | $45.76 | 6 | 0 | +35.26% |
| Rubino Alan L | director | 850 0.0018% | $45.76 | 1 | 0 | +14.22% |
| Durbin Scott | CFO | 0 0% | $45.76 | 4 | 1 | +21.07% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| BlackRock | $414.57M | 16.4 | 7.97M | +0.41% | +$1.69M | 0.01 | |
| Brown Capital Management | $257.55M | 10.19 | 4.95M | -27.39% | -$97.17M | 4.56 | |
| The Vanguard Group | $177.57M | 7.02 | 3.41M | +1.17% | +$2.05M | <0.01 | |
| State Street | $167.23M | 6.61 | 3.21M | +20.63% | +$28.6M | 0.01 | |
| Conestoga Capital Advisors, LLC | $121.27M | 4.8 | 2.33M | -0.37% | -$449,973.00 | 1.75 | |
| Fidelity Investments | $109.69M | 4.34 | 2.11M | +256.74% | +$78.94M | 0.01 | |
| RTW Investments, LP | $83.56M | 3.31 | 1.61M | -50% | -$83.56M | 1.24 | |
| GW&K Investment Management | $63.76M | 2.52 | 1.23M | -7.38% | -$5.08M | 0.56 | |
| Loomis, Sayles & Company | $57.55M | 2.28 | 1.11M | -3.09% | -$1.83M | 0.08 | |
| Macquarie Group | $56.32M | 2.23 | 1.08M | -5.54% | -$3.3M | 0.05 | |
| Geode Capital Management | $55.35M | 2.19 | 1.06M | +3.56% | +$1.9M | 0.01 | |
| New York State Common Retirement Fund | $55.21M | 2.18 | 1.06M | +0.04% | +$20,599.92 | 0.07 | |
| William Blair Investment Management | $43.78M | 1.73 | 841,677 | +0.81% | +$353,319.84 | 0.11 | |
| Congress Asset Management Co Ma | $43.51M | 1.72 | 836,481 | +509.08% | +$36.37M | 0.31 | |
| Geneva Capital Management LLC | $35.33M | 1.4 | 679,165 | +43.6% | +$10.73M | 0.62 | |
| Dimensional Fund Advisors | $33.36M | 1.32 | 641,215 | -12.21% | -$4.64M | 0.01 | |
| Federated Hermes | $32.43M | 1.28 | 623,350 | +11.23% | +$3.27M | 0.08 | |
| Ameriprise Financial | $31.76M | 1.26 | 610,475 | -9.59% | -$3.37M | 0.01 | |
| Royal Bank of Canada | $30.14M | 1.19 | 579,508 | +194.05% | +$19.89M | 0.01 | |
| JPMorgan Chase | $27.37M | 1.08 | 526,124 | -23.93% | -$8.61M | <0.01 | |
| Northern Trust | $27.29M | 1.08 | 524,624 | -2.76% | -$774,265.67 | 0.01 | |
| Nuveen | $27.04M | 1.07 | 519,727 | -14.36% | -$4.53M | 0.01 | |
| Invesco | $26.89M | 1.06 | 516,992 | +51.08% | +$9.09M | 0.01 | |
| Thrivent Financial For Lutherans | $24.09M | 0.95 | 463,083 | -16.34% | -$4.7M | 0.05 | |
| Morgan Stanley | $23.84M | 0.94 | 458,260 | -64.69% | -$43.68M | <0.01 | |
| Frontier Capital Management Co | $23.85M | 0.94 | 458,550 | +6.85% | +$1.53M | 0.22 | |
| Charles Schwab | $22.19M | 0.88 | 426,578 | +3.94% | +$842,099.78 | 0.01 | |
| Victory Capital Management Inc | $20.99M | 0.83 | 403,432 | +40.2% | +$6.02M | 0.02 | |
| Next Century Growth Investors LLC | $20.76M | 0.82 | 399,170 | +92.08% | +$9.95M | 1.8 | |
| Allspring Global Investments | $20.55M | 0.81 | 395,017 | -9.66% | -$2.2M | 0.03 | |
| Summit Creek Advisors, LLC | $18.06M | 0.71 | 347,219 | -21.22% | -$4.87M | 2.32 | |
| BNY Mellon | $17.88M | 0.71 | 343,724 | -4.38% | -$819,209.75 | <0.01 | |
| Scout Investments | $15.14M | 0.59 | 286,251 | -5.98% | -$962,621.24 | 0.38 | |
| TimesSquare Capital Management LLC | $12.78M | 0.51 | 245,711 | New | +$12.78M | 0.19 | |
| Comerica | $11.24M | 0.45 | 216,060 | +7.66% | +$799,857.94 | 0.05 | |
| Intrinsic Edge Capital Management Llc | $10.63M | 0.42 | 204,344 | 0% | +$0 | 0.9 | |
| Kent Lake Capital LLC | $10.4M | 0.41 | 200,000 | -33.33% | -$5.2M | 4.56 | |
| Goldman Sachs | $10.11M | 0.4 | 194,357 | -58.84% | -$14.45M | <0.01 | |
| Citigroup | $9.24M | 0.37 | 177,528 | +157.08% | +$5.64M | 0.01 | |
| Rafferty Asset Management Llc | $8.97M | 0.36 | 172,363 | +62.89% | +$3.46M | 0.03 | |
| HERITAGE ASSET MANAGEMENT INC | $8.74M | 0.34 | 165,300 | -8.9% | -$854,811.10 | 0.05 | |
| Fisher Asset Management Llc | $8.02M | 0.32 | 154,167 | -1.92% | -$156,736.23 | <0.01 | |
| Envestnet Asset Management Inc | $7.87M | 0.31 | 151,332 | +19.75% | +$1.3M | <0.01 | |
| RhumbLine Advisers | $7.4M | 0.29 | 142,275 | -0.19% | -$14,253.44 | 0.01 | |
| Mutual Of America Capital Management Llc | $7.18M | 0.28 | 137,984 | -5.13% | -$388,277.30 | 0.08 | |
| Bank of America | $7.12M | 0.28 | 136,849 | +85.1% | +$3.27M | <0.01 | |
| Renaissance Technologies | $7M | 0.28 | 134,492 | +72% | +$2.93M | 0.01 | |
| Legal & General | $6.98M | 0.28 | 134,141 | +0.67% | +$46,453.85 | <0.01 | |
| CastleArk Management, LLC | $6.78M | 0.27 | 130,250 | -12.01% | -$924,395.40 | 0.28 | |
| Silvercrest Asset Management Group Inc | $6.54M | 0.26 | 125,690 | New | +$6.54M | 0.05 |